Mr. Sébastien Tessier | Aerosolized Medication | Best Researcher Award

Mr. Sébastien Tessier | Aerosolized Medication | Best Researcher Award

Winnipeg Regional health Authority, Canada.

Sébastien Tessier is a distinguished healthcare leader, respiratory therapy expert, and academic with extensive experience in clinical innovation, leadership, and education. He has played a pivotal role in advancing healthcare services, particularly in respiratory therapy and interprofessional collaboration. With a strong background in leadership and healthcare innovation, he currently serves as Director of Clinical Services – Medicine, Family Medicine, and Rehab at the Winnipeg Regional Health Authority. Sébastien is fluent in both English and French and is actively engaged in research, teaching, and professional organizations that shape the future of respiratory therapy and healthcare management.

Profile

Orcid

Education 🎓

Mr. Sébastien Tessier is a dedicated professional with a strong academic background in business leadership and respiratory therapy. He earned his Master of Business Administration (Leadership) from Dalhousie University in Halifax, NS, between 2019 and 2021. Prior to this, he completed a Bachelor of Respiratory Therapy at the University of Manitoba, Winnipeg, MB, in 2014-2015. His educational journey began at La Cité Collégiale in Ottawa, ON, where he obtained an Advanced Diploma of Respiratory Therapy from 2009 to 2012. With a unique blend of healthcare expertise and leadership training, Mr. Tessier is well-equipped to contribute effectively to both clinical and managerial roles in the healthcare sector.

Professional Experience 👩‍🏫

Mr. Sébastien Tessier is a healthcare leader with extensive experience in clinical services, innovation, and education. Currently serving as Director of Clinical Service (Medicine, Family Medicine, Rehab) at the Winnipeg Regional Health Authority (2024–Present), he leads healthcare transformation across multiple hospitals and health centers. Previously, he was a Leadership Resident at WRHA (2023–2024), working closely with the CEO on strategic health projects. As Director of Innovation at Centre de Santé – St. Boniface (2022–2023), he spearheaded initiatives to enhance patient care. He is also a Sessional Instructor at the University of Manitoba (2022–Present) and has held key roles in clinical education and healthcare technology with Masimo Canada, Zoll Medical, and Shared Health Manitoba. With expertise in respiratory therapy, neonatal and pediatric critical care, and healthcare innovation, he continues to shape the future of patient care and medical education.

Research Interests 🔬

Sébastien Tessier’s research focuses on respiratory therapy advancements, healthcare innovation, and interprofessional collaboration. His work includes:

Optimization of aerosol drug delivery in pediatric care

Neonatal and pediatric respiratory care advancements

Healthcare leadership and policy innovation

Interprofessional education in respiratory therapy

Awards & Honors 🏆

Children’s Hospital Research Institute of Manitoba – Biology of Breathing Catalyst Grant (2020)

Louis-Phillipe Belisle Scholarship Award for Graduate Studies (2020)

Fellowship of the Canadian Society of Respiratory Therapists (FCSRT) (2020)

Publications 📚

Optimization of Albuterol Delivery via Anesthesia Bag in Pediatric Critical Care (Tessier, S., et al., 2025) – Pharmaceutics

Investigates innovative methods for optimizing albuterol delivery in pediatric critical care.

Enhances drug administration efficiency and patient outcomes.

Optimal Delivery of Aerosolized Medication to Mechanically Ventilated Pediatric and Neonatal Patients: A Scoping Review (Chartrand, L., Tessier, S., et al., 2022) – Canadian Journal of Respiratory Therapy

Reviews best practices for aerosolized medication administration in neonatal and pediatric critical care.

Provides evidence-based recommendations for improving respiratory therapy techniques.

 

 

Assist. Prof. Dr. Mircea Stoian | Ventilator | Best Researcher Award

Assist. Prof. Dr. Mircea Stoian | Ventilator | Best Researcher Award

County Hospital Tirgu Mures, Romania.

Dr. Mircea Stoian is a Romanian medical professional with extensive expertise in Anesthesia Intensive Care and Intensive Care Medicine. He is currently serving as a Lecturer at the George Emil Palade University of Medicine, Pharmacy, Science, and Technology in Târgu Mureș, Romania. With a strong clinical and academic background, he has contributed significantly to both medical practice and education. In addition to his teaching role, he also manages the Intensive Care Unit at the Mureș County Clinical Hospital, demonstrating his leadership in healthcare and research.

Profile

Orcid

Education 🎓

Dr. Stoian earned his Doctor of Medical Sciences from the University of Medicine, Pharmacy, Sciences, and Technology "George Emil Palade" in Târgu Mureș in 2013. His education includes certifications in Psychopedagogical Training and qualifications in Basic and Immediate Life Support (BLS/ILS) from the European Resuscitation Council (ERC). Additionally, he has completed specialized training in General Ultrasonography and Competence in Anesthesia Intensive Care from Lucian Blaga University and Mureș County Clinical Hospital.

Experience 💼

Dr. Stoian's career spans over two decades, with a range of clinical and research-focused roles. Currently, he is the Project Manager for research on miRNAs and inflammatory cytokines in sepsis and septic shock, financed by the University of Medicine, Pharmacy, Sciences, and Technology "George Emil Palade". His previous projects include coordinating ICU4COVID, an initiative focusing on Cyber-Physical Intensive Care Medical Systems for COVID-19. As an experienced Specialist Anesthesiologist, he has been involved in the Mureș County Clinical Hospital since 2007 and has led various postdoctoral research projects on the impacts of anesthesia on kidney function.

Research Interests 🔬

Intensive Care Medicine 🏥

Dr. Stoian’s primary focus lies in Intensive Care Medicine, where he explores critical aspects of managing severe health conditions in ICU settings. His work addresses the complex challenges of providing life-saving care for patients suffering from acute medical conditions.

Pathophysiology of Sepsis ⚠️

Dr. Stoian conducts research on the pathophysiology of sepsis, a life-threatening condition that results from infections spreading throughout the body. His research aims to better understand how sepsis develops, progresses, and how early interventions can improve patient survival rates.

Role of miRNAs in Diagnostics 🧬

Another area of interest is the role of microRNAs (miRNAs) in diagnostics. Dr. Stoian investigates how these small non-coding RNAs can be used as biomarkers for detecting sepsis and other critical conditions. His work holds promise for advancing diagnostic techniques in Intensive Care Units (ICUs).

Inflammatory Cytokine Interactions 🔥

Dr. Stoian explores how inflammatory cytokines interact during sepsis and other critical illnesses. These molecules are crucial for the body’s immune response, and understanding their role can help identify targets for therapy and improve patient care in ICU environments.

Anesthesia Effects on Kidney Function 🏥💉

Dr. Stoian also focuses on the effects of anesthesia on kidney function, studying changes in renal permeability and how general anesthesia can impact kidney health. This research aims to mitigate the adverse effects of anesthesia on the kidneys, ultimately improving patient recovery after surgery.

Ultrasonography for Critical Care Diagnostics 📸

An additional interest of Dr. Stoian is the use of ultrasonography for diagnostic purposes in critical care. By improving the use of ultrasound in diagnosing conditions like sepsis or cardiac arrest, Dr. Stoian’s work enhances the ability of ICU teams to make timely and accurate decisions.

Publications Top Notes 📑

Mechanical Ventilator-Associated Pneumonia in the COVID-19 Pandemic Era: A Critical Challenge in the Intensive Care Units
Published: 2025-01-03 | Journal: Antibiotics

The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes
Published: 2024-11-03 | Journal: Medicina

Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy
Published: 2024-09-27 | Journal: International Journal of Molecular Sciences

Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”
Published: 2024-08-02 | Journal: Pathogens

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go
Published: 2024-06 | Journal: Biomedicines